Progesterone Biosynthesis Pathway Explained
In the human body, progesterone is an endogenous steroid hormone synthesized primarily in the corpus luteum of the ovary, the adrenal cortex and, during pregnancy, the placenta. Its biosynthesis follows the classic steroidogenesis pathway starting from cholesterol.
The core biosynthetic sequence proceeds as follows:
- Cholesterol uptake and transport: Cholesterol is transported into the mitochondria of steroidogenic cells, the rate-limiting step regulated by the StAR protein.
- Conversion to pregnenolone: The cholesterol side-chain cleavage enzyme (CYP11A1) cleaves the cholesterol side chain, producing pregnenolone - the common precursor for all steroid hormones.
- Conversion to progesterone: The enzyme 3β-hydroxysteroid dehydrogenase (3β-HSD) catalyzes the oxidation of the 3β-hydroxyl group and isomerization of the double bond, converting pregnenolone into progesterone.
In endocrine research, this endogenous pathway is the reference for studying progesterone physiology and receptor pharmacology. Industrial progesterone production follows related steroid transformation principles but uses optimized chemical and semi-synthetic processes designed for scalable pharmaceutical manufacturing.

Industrial Progesterone API Manufacturing Process
Commercial-scale progesterone API is produced via semi-synthetic manufacturing routes, starting from renewable plant-derived sterol feedstocks such as diosgenin or phytosterols. This approach is the global industry standard, balancing production efficiency, product quality and environmental impact.
Progesterone API Manufacturing Workflow
| Stage | Key Process | Quality Control |
|---|---|---|
| Raw Material | Plant sterol qualification & incoming inspection | Identity verification & purity testing |
| Transformation | Multi-step steroid conversion reactions | In-process HPLC monitoring at each stage |
| Purification | Impurity removal via extraction & chromatography | Chemical impurity profile analysis |
| Crystallization | Crystal form & particle size control | Particle size distribution testing |
| Final Release | Full panel QC testing & batch review | Official COA issuance |

Step 1: Raw Material Selection & Incoming QC
The production process begins with qualified starting materials, typically plant-derived steroid intermediates. All incoming raw materials undergo strict incoming quality control testing, including identity verification by IR or LC-MS and purity assessment by HPLC, to ensure they meet predefined specifications.
Starting material quality is the first and most critical quality gate. Impurities or structural variants carried over from raw materials are difficult and costly to remove in later purification steps, so reputable manufacturers maintain strict vendor qualification and incoming inspection protocols.
Step 2: Multi-Step Steroid Transformation
The sterol starting material undergoes a sequence of controlled organic chemical reactions to construct the progesterone molecular structure. Key reaction steps typically include:
Protection of reactive hydroxyl groups
Selective oxidation of functional groups
Side chain cleavage and modification
Double bond isomerization
Deprotection of functional groups
Each reaction step is run under precisely controlled temperature, pressure, reagent ratio and agitation conditions. In-process testing (IPT) by HPLC is performed at every stage to verify reaction completion and monitor byproduct formation, ensuring consistent intermediate quality before moving to the next step.
Step 3: Crude Product Purification
After the final synthetic step, crude progesterone is isolated from the reaction mixture via liquid-liquid extraction, filtration and washing. The crude material then undergoes primary purification to remove process impurities, unreacted starting materials and reaction byproducts.
Depending on the specific process route, purification may include:
Liquid-liquid extraction with selective solvent systems
Adsorptive filtration through activated carbon
Column chromatography for high-purity grades
pH adjustment and precipitation to remove acidic/basic impurities
Step 4: Recrystallization & Particle Control
Purified progesterone is recrystallized under tightly controlled process conditions. Crystallization is the most critical step for defining final product quality attributes including:
Final HPLC purity (typically raised to ≥99.0% after recrystallization)
Crystal form and polymorphism
Particle size distribution (critical for micronized progesterone grades)
Residual solvent levels
By controlling solvent composition, cooling rate, seeding strategy and agitation speed, manufacturers can tailor progesterone powder properties to meet specific formulation requirements, such as micronized particle size for oral bioavailability enhancement.
Step 5: Drying, Milling & Final Quality Release
Crystallized progesterone is vacuum dried to reduce residual solvents to pharmacopeia-compliant levels. For micronized grades, the dried powder is milled and classified to achieve the specified particle size distribution.
Final finished batches are sampled and undergo comprehensive QC testing. Only material that passes all specification requirements is released, packaged and accompanied by a full batch Certificate of Analysis.
Quality Testing During Progesterone Production
Rigorous quality control is implemented at every stage of progesterone manufacturing, from incoming raw materials through finished product release. The core testing panel for finished progesterone API includes:
- Identity testing: Confirmed by LC-MS and/or infrared spectroscopy (IR) to verify correct chemical structure.
- Purity assay: Quantitative determination by HPLC, typically meeting ≥99.0% purity for pharmaceutical grade material, with individual known impurities controlled below pharmacopeia limits.
- Related substances: Full profiling and quantification of all process-related and degradation impurities.
- Residual solvents: Tested by headspace GC to ensure compliance with ICH Q3C limits.
- Heavy metals: Tested for lead, arsenic, cadmium, mercury and other elemental impurities per ICH Q3D guidelines.
- Physicochemical testing: Melting point, specific optical rotation, loss on drying and residue on ignition.
- Microbial testing: Total aerobic count, yeast/mold count and absence of specified pathogens, as appropriate for API grade.
For GMP-grade material, all testing is performed in a QC laboratory operating under GLP principles, with full traceability of test records, instruments and reagents.

What Quality Documents Should API Buyers Request?
| Document | Core Purpose |
|---|---|
| Batch Certificate of Analysis (COA) | Official batch quality verification with full test results |
| HPLC Chromatogram Report | Quantitative purity confirmation and impurity profile |
| LC-MS Spectra Report | Molecular identity and structural correctness confirmation |
| Safety Data Sheet (MSDS) | Handling, storage and hazard safety information |
| Stability Study Data | Shelf-life validation and storage condition support |
Why Manufacturing Technology Matters for API Buyers
For pharmaceutical and research buyers, the manufacturer's synthesis technology and process capability are far more important than simply comparing quoted prices. Advanced manufacturing capability delivers four key buyer benefits:
- Superior Batch Consistency Well-optimized, fully validated synthesis processes produce progesterone API with highly consistent purity, impurity profiles and physical properties batch after batch. This consistency eliminates formulation variability, reduces regulatory risk and ensures reproducible research results.
- Reliable Supply Stability Manufacturers with in-house process development and full vertical integration - from intermediate production through finished API - are far less vulnerable to supply chain disruptions, raw material shortages or price volatility. They can also scale production more quickly to meet growing customer demand.
- Strong Regulatory Compliance Mature, well-documented manufacturing processes are easier to validate and support successful regulatory filings. Suppliers with robust process understanding can provide comprehensive DMF dossiers, technical packages and regulatory support to help customers achieve faster market approval for finished products.
- Customization Capability Technically strong manufacturers can develop custom progesterone specifications - such as specific particle size ranges, low-residual-solvent grades or custom packaging - to match unique formulation or research requirements.
For a broader view of market dynamics and supplier landscape, see our 2026 analysis of progesterone API market trends and supply chain outlook. For a full breakdown of vendor evaluation criteria, see our guide on how to select a reliable progesterone API supplier. For a deeper look at progesterone receptor signaling and physiological function, see our guide to progesterone receptor mechanism of action.

FAQ
Q1: What is Progesterone API?
A: Progesterone API is the pharmaceutical-grade active pharmaceutical ingredient form of progesterone, manufactured to meet pharmacopeia standards and used as the raw active ingredient for producing finished progesterone drug products.
Q2: What is Progesterone CAS number?
A: The CAS registry number for progesterone is 57-83-0.
Q3: How is Progesterone manufactured?
A: Industrial progesterone is manufactured via semi-synthetic processes starting from plant-derived sterol precursors. The process includes multi-step chemical synthesis, purification, recrystallization and comprehensive quality control testing.
Q4: How to verify Progesterone API quality?
A: Progesterone API quality is verified through analytical testing including HPLC for purity, LC-MS for identity, residual solvent testing and heavy metal analysis. All results are documented in a batch-specific Certificate of Analysis (COA).
Q5: Where to buy Progesterone powder?
A: High-quality progesterone powder is available from GMP-certified steroid API manufacturers. China-based manufacturers are a leading global source for both commercial GMP-grade and research-grade progesterone API.
Q6: What is the difference between progesterone synthesis and biosynthesis?
A: Biosynthesis refers to the natural biological pathway that produces progesterone from cholesterol in living organisms. Industrial synthesis refers to commercial pharmaceutical manufacturing processes that produce progesterone using controlled chemical and semi-synthetic technologies optimized for large-scale production.
Source GMP Progesterone API for Pharmaceutical Manufacturing
HDM BIO manufactures progesterone API using optimized semi-synthetic production processes and strict GMP quality management. Our pharmaceutical grade progesterone powder meets USP/EP/CP standards with ≥99.0% HPLC purity, full batch documentation and global shipping support.
HDM BIO provides pharmaceutical-grade progesterone API manufactured under GMP-aligned quality systems, with: ✓ ≥99% HPLC verified purity ✓ Batch-specific COA with full test data ✓ Complete HPLC and LC-MS analytical reports ✓ Custom specification and particle size support ✓ Full global export documentation package
We offer both standard and custom specifications, including micronized grades, to meet formulation and research requirements.
For product specifications and pricing, visit our Progesterone Powder product page.
Related Resources
Progesterone API Market Trends & Supply Chain Outlook 2026
Progesterone Mechanism of Action & Receptor Signaling Guide
Complete Guide to Selecting a Progesterone API Supplier
Steroid API Manufacturing Quality Standards Overview





